Although the preclinical studies have demonstrated amelioration of inflammatory phenotypes through c-Maf intervention in animal models in autoimmune diseases, the exact mechanisms and long-term effectiveness still need further investigations. The gene discussed is MAF; the disease is autoimmune disease.